IIM
LFCR icon

INTECH Investment Management’s Lifecore Biomedical LFCR Stock Holding History

INTECH Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,724
Closed -$95.9K – 2242
2025
Q4 		$95.9K Sell
11,724
-1,678
-13% -$12.4K ﹤0.01% 2165
2025
Q3 		$98.6K Sell
13,402
-3,861
-22% -$29.2K ﹤0.01% 2271
2025
Q2 		$140K Buy
17,263
+6,660
+63% +$44.9K ﹤0.01% 2202
2025
Q1 		$74.6K Sell
10,603
-660
-6% -$4.1K ﹤0.01% 2378
2024
Q4 		$83.7K Buy
+11,263
New +$71.9K ﹤0.01% 2252

Other funds holding LFCR

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INTECH Investment Management's LFCR Position: Q1 2026 in Review

INTECH Investment Management sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 11,724 shares — an estimated $95.9K sold.

INTECH Investment Management first reported a position in LFCR in Q4 2024 and held it in 5 quarters. The position peaked at $140K in Q2 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • INTECH Investment Management reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 11,724 Lifecore Biomedical shares in Q1 2026, an estimated $95.9K.
  • INTECH Investment Management first reported a position in Lifecore Biomedical in Q4 2024 and held it in 5 quarters.
  • INTECH Investment Management's Lifecore Biomedical position peaked at $140K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.